1 / 33

Replication of a Home-Based Palliative Care Program: A Multi-site Study

Susan Enguidanos, PhD Director, Research Center Partners in Care Foundation Assistant Professor Davis School of Gerontology University of Southern California sengui@aol.com. Replication of a Home-Based Palliative Care Program: A Multi-site Study. Goals of Discussion.

yardley
Download Presentation

Replication of a Home-Based Palliative Care Program: A Multi-site Study

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Susan Enguidanos, PhD Director, Research Center Partners in Care Foundation Assistant Professor Davis School of Gerontology University of Southern California sengui@aol.com Replication of a Home-Based Palliative Care Program: A Multi-site Study

  2. Goals of Discussion • Brief overview of End-of-Life Care • Introduction to Home-based Palliative Care • Evidence of Effectiveness • Policy Implications • Next Steps

  3. Definition of Terms • Hospice: Medicare benefit for last 6 months of life for those with terminal illness. • Palliative Care: pain and symptom relief provided for those with serious illness.

  4. Challenges in ProvidingEnd-of-Life Care • Fragmentation of care • Aging population • Costs of medical care • 25% of Medicare revenue is spent on 5% who die each year • Average cost of care in last year of life is $26,000 (1996 costs) • Average cost of care in last 2 years $ 58,000

  5. A dichotomous intent Curative / life-prolonging therapy Presentation Death Relieve suffering (hospice)

  6. Barriers to Hospice • Systemic • Physician • Patient

  7. Impact of Barriers • Patients are referred late to Hospice • Median length of stay=22 days • Patients often die in pain • Patient EOL preferences are not considered • Patients die in the hospital (60%)

  8. Home Based Palliative Care Model • Bridge traditional medical care and Hospice care • In home end-of-life care for patients with one year life expectancy • Blended model of care • Shift focus of care from hospital to home

  9. Curative / remissive therapy Presentation Death Palliative care Hospice

  10. Core Components of Palliative Care • Interdisciplinary team • Physical, medical, psychological, social & spiritual support • Care provided in home • Patient & family education & training • Coordinated, patient-centered plan of care

  11. Core Components of Palliative Care • Pain & symptom management • comprehensive primary care to manage underlying conditions • aggressive treatment of acute exacerbation per patient and family request • 24 hour phone support, visits if necessary • Volunteer & bereavement services • Transfer to hospice if appropriate

  12. Palliative Care vs. Hospice • Physicians not required to give a 6 month prognosis • Patients do not have to forego curative care • Palliative care physician coordinates care to prevent service fragmentation

  13. Progression ofIn Home Palliative Care Model • Pilot study conducted in Kaiser Permanente (KP) Southern California in 1998 • Comparison group study KP Southern California in 1999 • Won National KP Voh’s Award for Quality in 2002

  14. Project Overview Funded by Garfield Memorial Fund • Randomized controlled trial in Kaiser Permanente Colorado & Hawaii (2002-2004) • Study period: 2 years (approximately 18 months of data collection) • 310 patients recruited from 2 sites • Colorado n=150, Hawaii n=160

  15. Data Collection • Phone interviews at baseline and every 30 days up to 120 days • Functional status • Satisfaction • At death or discharge from study • Service utilization • Medical care cost data • Site of death

  16. Garfield Multisite Study Design

  17. Enrollment Criteria • KP Health Plan Member • Not receiving Hospice • Diagnosis of congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD), or cancer • 1 or more emergency department/hospital visits in 12 months • Palliative Performance Scale 7 or less • Life expectancy about 1 year • Primary care physician “would not be surprised” if the patient died in the next year

  18. Study Groups • Usual Care (UC) • One visit by home health nurse to assess for further need • Access to all usual medical care services • Palliative Care (PC) • Multiple home visits provided by interdisciplinary palliative team (physician, nurse, social worker, HHA, volunteers, pastor on request) • Access to all usual medical care services

  19. 718 Potential Participants referred to the study Excluded (n=408): 199 Ineligible 67 Admitted to Hospice 59 Refused 35 Died 26 In other study 19 Other 310 Randomized 155 Assigned to Intervention: 2 Withdrew 8 died before receiving care 155 Assigned to Usual Care 3 withdrew 145 Included in Final Analysis 152 Included in Final Analysis Patient Flowchart

  20. Mean Age 74 (sd=12) 77% of study participants were over 65. The age range spanned from 38-101 51% Male Primary Diagnosis 46.5% Cancer 32.7% CHF 20.8% COPD Mean of 2.5 major medical conditions (sd=1.4) Marital Status 52.2% Married 29.3% Widowed 8.1% Single 6.7% Divorced 3.7% Unknown Ethnicity 63% Caucasian 16% Asian/Pacific Islanders 13% Hawaiian 5% Latino 2% African American 1% Other Demographics of Study Participants

  21. Baseline Group Comparisons • No differences between study groups at enrollment in terms of: • Demographics: ethnicity, age, gender, marital status, income level • Palliative Performance Scale • Palliative Care more satisfied with services at baseline • Usual Care had significantly more days on service before death

  22. Baseline Variables

  23. Patient Satisfaction Percent Very Satisfied at Enrollment (n=277), 30 Days (n= 216), 60 Days (n=168) and 90 Days Post-enrollment (n= 149) by Study Group

  24. Adjusted Mean Satisfaction Scores at Enrollment and 90 Days Post-enrollment by Study Group P=.004 P=.4

  25. Acute Care Service Use (n=297) * P<.01

  26. Unadjusted Medical Service Use (n=297) * P<.01

  27. Total Service Costs • Adjusted costs of care for those in PC were 32.6% less than those receiving UC • Saves $7,551 n=292 p<.001 F=16.66

  28. Average Cost Per Day • Adjusted average per day cost of care by study group based on the average days on service • PC = $95 • UC = $213 n=292 p<.001

  29. Site of Death (n=217) • Studies show that most people prefer to die at home* • Patients enrolled in the Palliative Care program were significantly more likely to die at home (71% vs. 51%: p=.001) P=.013 *(Townsend, Frank, Fermont, et al., 1990; Karlsen & Addington-Hall, 1998; Hays et al., 2001)

  30. "We are so grateful our mother could participate in your Palliative Care Program.  What a gift!  It made possible an independent life until her death. Thank you for patience, devotion and capable care." “But there were moments of stark beauty too.  A hospice priest counseled us about the freedom that comes from letting go of control.  My father thought quietly, then told me as I helped him back to bed that this realization had been a powerful assist, an emotional turning point.  Each day, he told my sister later, had become a gift, not a burden." Family Comments

  31. Implications • First rigorous study to examine the effectiveness of an in-home, community-based, palliative care program • Provides strong clinical and financial evidence supporting the provision of palliative care in the home • Tremendous implications for improving end of life care for terminally ill • KP adapted as standard care throughout Southern CA & moving to national

  32. Policy Implications • Evidence provided here and in a previous study support the need for fundamental changes in the design of our health care system to bridge care between standard medical care and hospice care. • Modification of Hospice benefit or development of a new “pre-hospice” benefit

  33. Future Studies • Replicate within alternate funding structure, e.g., medical group • Demonstration project to test benefited model of care, e.g., hospice • Test similar chronic care model provided upstream, earlier in disease trajectory

More Related